Conference abstractPublished 2016

Nurr1: A new investigation target for Parkinsons disease

Authors: Weidong Le

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Parkinson disease (PD) is the second most common neurodegenerative disease in adults mainly with manifesting movement disorder symptoms. The loss of dopamine (DA) neurons in the substantia nigra (SN) is the pathological hallmark of PD. Although many PD related genes and environmental factors have been identified, the mechanisms underlying the loss of DA neurons in PD are still poorly understood. Previously, we have documented that Nurr1, a gene regulating DA neuron differentiation is a risk factor for PD. We have also found that down-regulation of Nurr1 can cause DA neuron degeneration, increase Ã?±-synuclein expression, and induce glia-mediated inflammation and neuronal injury. Therefore, we believe that Nurr1 may play an important role in the development of PD. Recently, we documented that small molecules acting on Nurr1 transcription site can enhance DA neuron transmission and survival under the condition of proteasome inhibition mediated DA neuron degeneration. Currently, we are evaluating Nurr1-enhancing drugs for the potential of anti-PD therapy and measuring the Nurr1 level in the CSF of PD patients to determine if change of Nurr1 level is associated with the disease course of PD.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Neurology & Neurophysiology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neurology & Neurophysiology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Weidong Le”